Harold A. Kessler

Overview

Best Publications

• Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315

  Michael Marcel Lederman;Elizabeth Connick;Alan Landay;Daniel R. Kuritzkes

  627
  Citations

• A Controlled Trial Comparing Foscarnet with Vidarabine for Acyclovir-Resistant Mucocutaneous Herpes Simplex in the Acquired Immunodeficiency Syndrome

  Sharon Safrin;Clyde Crumpacker;Pam Chatis;Roger Davis

  436
  Citations

• ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.

  L A Pinto;J Sullivan;J A Berzofsky;M Clerici

  328
  Citations

• ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.

  Robert L. Murphy;Scott Brun;Charles Hicks;Joseph J. Eron

  306
  Citations

• Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.

  Hernan Valdez;Elizabeth Connick;Elizabeth Connick;Kimberly Y. Smith;Kimberly Y. Smith;Michael M. Lederman

  296
  Citations

• HIV-Specific T-Helper Activity in Seronegative Health Care Workers Exposed to Contaminated Blood

  Mario Clerici;James M. Levin;Harold A. Kessler;Alan Harris

  294
  Citations

• Immune Reconstitution in the First Year of Potent Antiretroviral Therapy and Its Relationship to Virologic Response

  Elizabeth Connick;Michael Marcel Lederman;Brian L. Kotzin;John Spritzler

  253
  Citations

• A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.

  Calvin J. Cohen;Susan Hunt;Michael Sension;Charles Farthing

  247
  Citations

• Thymic Size and Lymphocyte Restoration in Patients with Human Immunodeficiency Virus Infection after 48 Weeks of Zidovudine, Lamivudine, and Ritonavir Therapy

  Kimberly Y. Smith;H. Valdez;A. Landay;J. Spritzler

  245
  Citations

• Guidelines for the Treatment of Cytomegalovirus Diseases in Patients With AIDS in the Era of Potent Antiretroviral Therapy: Recommendations of an International Panel

  R J Whitley;M A Jacobson;D N Friedberg;G N Holland

  228
  Citations

• Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen

  Hernan Valdez;Kimberly Y. Smith;Alan Landay;Elizabeth Connick

  225
  Citations

• A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS

  Jacob Lalezari;Tim Schacker;Judith Feinberg;Joseph Gathe

  211
  Citations

• Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy.

  Richard W. Price;Constantin T. Yiannoutsos;David B. Clifford;Lawrence Zaborski

  195
  Citations

• Safety and Antiviral Activity at 48 Weeks of Lopinavir/Ritonavir plus Nevirapine and 2 Nucleoside Reverse-Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1-Infected Protease Inhibitor-Experienced Patients

  Constance A. Benson;Steven G. Deeks;Scott C. Brun;Roy M. Gulick

  194
  Citations

• Correlation of serum HIV antigen and antibody with clinical status in HIV-infected patients.

  Deborah A. Paul;Lawrence A. Falk;Harold A. Kessler;Robert M. Chase

  187
  Citations

• In vivo analysis of Fas/FasL interactions in HIV-infected patients.

  Andrew D. Badley;David H. Dockrell;Alicia Algeciras;Steve Ziesmer

  182
  Citations

• Once-Daily versus Twice-Daily Lopinavir/Ritonavir in Antiretroviral-Naive HIV-Positive Patients: A 48-Week Randomized Clinical Trial

  Joseph J. Eron;Judith Feinberg;Harold A. Kessler;Harold W. Horowitz

  176
  Citations

• Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study.

  Charles Hicks;Martin S. King;Roy M. Gulick;A. Clinton White

  170
  Citations

• Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an acute viral syndrome.

  Harold A. Kessler;Bernard Blaauw;Joel Spear;Deborah A. Paul

  162
  Citations

• Molecular Analysis of Decreased Interleukin-12 Production in Persons Infected with Human Immunodeficiency Virus

  Claire Chougnet;Thomas A. Wynn;Mario Clerici;Alan L. Landay

  162
  Citations

• Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.

  Mary A. Albrecht;Ronald J. Bosch;Scott M. Hammer;Song-Heng Liou

  161
  Citations

• Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients.

  Keith Fowke;Ronald D'Amico;David Chernoff;John Pottage

  155
  Citations

• Characterization of Viral Dynamics in Human Immunodeficiency Virus Type 1-Infected Patients Treated with Combination Antiretroviral Therapy: Relationships to Host Factors, Cellular Restoration, and Virologic End Points

  Hulin Wu;Daniel R. Kuritzkes;Daniel R. McClernon;Harold Kessler

  144
  Citations

• Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero.

  Ofelia A. Olivero;Gene M. Shearer;Claire A. Chougnet;Andrea A.S. Kovacs

  140
  Citations